Background: Arterial thromboses, including cerebral infarction, are a rare complication of the nephrotic syndrome.
T he association between ischemic strokes in young adults and hypercoagulable states is well recognized. In a recent review, Hart and Kanter' mention that more than a dozen primary hematologic disorders have been linked with ischemic stroke. One of the hypercoagulable states, the nephrotic syndrome, has been associated with both venous and arterial thromboses. Reports of cerebral infarction and nephrotic syndrome date back to sion and preeclampsia during a prior pregnancy. The patient had smoked one-half to one pack of cigarettes daily for an unspecified length of time. Enalapril and atenolol had been prescribed for her in the past, but compliance was questionable.
Upon initial evaluation, the patient was afebrile, with a blood pressure of 180/110 mm Hg. She was disoriented but without obvious localizing neurological signs. Her right upper extremity was cool, pale, and without palpable pulses. A dampened radial pulse was obtained by Doppler.
After receiving a 5,000-unit bolus of intravenous heparin, the patient was transferred to our hospital. On admission, her blood pressure was 204/102 mm Hg. Her neurological exam was notable for an expressive aphasia and right hemiparesis. An ischemic right upper extremity was again noted.
Laboratory studies were notable for an erythrocyte sedimentation rate of 108 mm/hr. The prothrombin time was 11.9 seconds (normal level, 10-13 seconds), partial thromboplastin time was 19.0 seconds (normal, 25-38 seconds), and platelet count was 754,000/mm3 (normal, 150-400/mm3). There was a decreased serum albumin concentration of 2.6 g/dL (normal, 4.0-6.5 g/dL) and a serum cholesterol level of 568 mg/dL. Her hematologic profile was notable for decreased free protein S of 45% (normal, 60-86%), normal total protein S, and an elevated fibrinogen level of 620 ng/dL (normal, 150-400 ng/dL). The 
As with the nephrotic syndrome in general, the reported cases of cerebral infarction and nephrotic syndrome have lacked a unifying hematologic factor. In both cases reported by Marsh et al,4 the patients had increased fibrinogen levels, with normal antithrombin III; one also had a decreased level of free protein S. In both cases described by Fuh et al,5 the patients had decreased levels of antithrombin III, as did the patient of Parag et al. 3 One patient of Fuh et al had a decreased protein C level as well.
Our patient displayed an elevated fibrinogen level.
Because fibrinogen serves as a major determinant of plasma viscosity, this may have contributed in part to her thromboses. She also had reduced free protein S but normal total protein S, which would imply a reduced activity of protein S since the free fraction is the active fraction. The decrease in protein S is thought to be secondary to increased urinary losses, and this protein has been found in the urine of nephrotic patients.12
The patient outlined in the current report is the first young adult to be described with such malignant central nervous system hypercoagulability. rapid that a 24-hour urine collection was not feasible. However, she did manifest other characterisitcs of the nephrotic syndrome (proteinuria, hypoalbuminemia, and hypercholesterolemia) and had evidence of early membranous nephropathy. We agree with others that urinalysis remains an important element in the assessment of the stroke patient and that careful evaluation for a prothrombotic disorder is warranted in young stroke patients. The present case serves as a reminder that the clinical and laboratory findings of nephrotic syndrome may signal the onset of a fulminant hypercoagulable state that can lead to infarctions in multiple vascular territories.
